What part of the brain is activated when individuals with a history of addiction to alcohol or opioids experience urges to use these substances?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brain Regions Activated During Substance Craving in Individuals with Prior Addiction

When individuals with a history of alcohol or opioid addiction experience urges to use, widespread activation occurs across multiple interconnected brain regions, most prominently involving the limbic system (amygdala, striatum, hippocampus, thalamus), frontal cortical areas (anterior cingulate cortex, dorsolateral prefrontal cortex, orbitofrontal cortex), and midbrain regions. 1

Primary Neural Circuits Involved in Craving

Limbic System Activation

The limbic structures show particularly robust activation during drug cue exposure in individuals with opioid use disorder:

  • Amygdala: Consistently activated in response to drug-related cues, encoding emotional salience and conditioned associations with substance use 1
  • Striatum (nucleus accumbens, caudate, putamen): Shows heightened neural response to drug cues, reflecting the overvaluation of drug-related stimuli relative to natural rewards 1
  • Hippocampus: Activated during cue-triggered craving, mediating memory associations between environmental contexts and prior drug use 1
  • Thalamus: Demonstrates increased activity during drug cue exposure 1

Frontal Cortical Regions

Multiple prefrontal areas show activation patterns that reflect both craving and impaired self-regulation:

  • Orbitofrontal cortex (OFC): Shows increased activity to drug cues, particularly sensitive to acute drug administration effects 1
  • Anterior cingulate cortex (ACC): Consistently activated across studies examining heroin cue reactivity 1
  • Dorsolateral prefrontal cortex (dlPFC): Demonstrates heightened response to drug-related stimuli 1
  • Medial prefrontal cortex: Reliably activated to drug cues across multiple substances according to meta-analyses 1

Midbrain and Brainstem Structures

  • Ventral tegmental area (VTA): Shows activation during early phases of drug cue exposure 1
  • Midbrain regions: Demonstrate increased neural response to heroin-related cues 1

Neurochemical Basis of Craving

Dopamine-Mediated Reward Pathway

The pleasurable effects of opioids and alcohol are triggered by dopamine release in the nucleus accumbens, a key reward region 1. This creates learned associations between drug administration and pleasure through conditioning mechanisms 1. The mesolimbic dopamine system, ascending from the ventral tegmental area to the nucleus accumbens, represents the critical pathway for drug reinforcement 2, 3, 4.

Opioid System Involvement

Activation of mu-opioid receptors in the ventral tegmental area and mu- and delta-opioid receptors in the nucleus accumbens enhances dopamine concentration in the nucleus accumbens, mediating reinforcing effects 3. For alcohol specifically, the endogenous opioid reward system plays a key role, with alcohol consumption potentially serving to compensate for inherent deficits in this system 4.

Clinical Implications and Modulation

Medication Effects on Cue Reactivity

Neural responses to drug cues are sensitive to pharmacological manipulation:

  • Methadone: Daily administration decreases activity in orbitofrontal, insular, amygdalar, and hippocampal regions in response to drug cues 1
  • Naltrexone (opioid antagonist): Reduces subcortical activity (amygdala, striatum, hippocampus) to drug cues 1
  • Buprenorphine (partial agonist): Decreases subcortical activity to drug cues 1

Abstinence Effects

Corticolimbic responses to drug cues appear to decrease following prolonged abstinence, though these changes persist even years after drug discontinuation 1. The neuroadaptations underlying addiction represent chronic brain changes affecting reward, conditioning, self-regulation, and stress reactivity circuits 1.

Stress and Negative Reinforcement Systems

Beyond reward circuitry, the brain stress systems become recruited during addiction:

  • Extended amygdala and bed nucleus of stria terminalis: Mediate stress-triggered relapse through corticotropin-releasing factor (CRF) and dynorphin-κ opioid systems 5
  • Medial prefrontal cortex: CRF activation parallels deficits in executive function that facilitate compulsive-like responding 5

Important Clinical Caveats

The widespread nature of brain activation during craving reflects that addiction involves not simply a single "addiction center" but rather dysregulation across multiple interconnected neural systems 1. The medial prefrontal cortex and cingulate cortex are the most reliably activated regions across different substances, and activity in these regions may predict relapse 1.

Repetition of drug exposures disrupts dopamine-modulated striatocortical pathways, impairing prefrontal cortical regions necessary for self-regulation and control, which drives the progression from voluntary to compulsive drug use 1. This represents a neuroanatomical progression from ventral striatal (nucleus accumbens) to dorsal striatal control over drug-seeking behavior 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Addiction and brain reward and antireward pathways.

Advances in psychosomatic medicine, 2011

Research

Endogenous opioids and addiction to alcohol and other drugs of abuse.

Current topics in medicinal chemistry, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.